Close Menu

At Forbes' Techonomy 2011 meeting held in Tucson, Ariz., this week, Singularity University's Andrew Hessel called synthetic biology "one of the most powerful technologies in the world," contributor Alyson Krueger reports. "We're going to make synthetic human genomes and edit them, and we’re going to end up with IVF technologies that can boot them," Hessel continued.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.

The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.

The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.

In PLOS this week: genome instability in Aicardi-Goutières Syndrome, introduction of SARS-CoV-2 to the Colombian Amazon, and more.